Premium
Second‐look hysteroscopy after antitubercular treatment in infertile women with genital tuberculosis undergoing in vitro fertilization
Author(s) -
Bahadur Anupama,
Malhotra Neena,
Mittal Suneeta,
Singh Neeta,
Gurunath Sumana
Publication year - 2010
Publication title -
international journal of gynecology and obstetrics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.895
H-Index - 97
eISSN - 1879-3479
pISSN - 0020-7292
DOI - 10.1016/j.ijgo.2009.08.031
Subject(s) - medicine , in vitro fertilisation , hysteroscopy , genital tuberculosis , infertility , gynecology , obstetrics , tuberculosis , andrology , pregnancy , pathology , genetics , biology
Abstract Objectives To assess the efficacy of antitubercular treatment on the uterine cavity in infertile women diagnosed with genital tuberculosis using second‐look hysteroscopy. Methods A total of 70 women with genital tuberculosis who underwent second‐look hysteroscopy were enrolled in the study. They were started on antitubercular drugs and followed up after 6 months of therapy with second‐look hysteroscopy. McNemar's χ 2 test was used to compare the hysteroscopy findings before and after antitubercular treatment. Results Antitubercular treatment improved hysteroscopy findings in women with thin or flimsy adhesions (grade I), singular dense adhesions (grade II), and occluding adhesions at the internal os (grade IIa) ( P < 0.01). Patients with extensive adhesions, extensive endometrial scarring, fibrosis, and a tubular cavity showed no improvement after antitubercular treatment. Mean endometrial thickness of the 70 patients on day 21 prior to starting drug therapy was 6.8 mm, which increased to 8.1 mm after 6 months of treatment. Conclusion Considering the exorbitant cost of assisted reproductive technology in low‐resource countries, it is necessary to consider reassessment of the uterine cavity prior to beginning such treatment.